Alpha Teknova Inc Cash Flow Conversion Efficiency
Alpha Teknova Inc cash flow conversion efficiency. Based on the latest financial reports, Alpha Teknova Inc (TKNO) has a cash flow conversion efficiency ratio of -0.052x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.36 Million) by net assets ($64.92 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Alpha Teknova Inc (2019–2025)
Cash flow conversion efficiency of Alpha Teknova Inc from 2019 to 2025. This chart illustrates how Alpha Teknova Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Alpha Teknova Inc (TKNO) stock price for real-time trading data and today's change.
Alpha Teknova Inc Cash Flow Conversion Ratio Explained
Alpha Teknova Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Alpha Teknova Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alpha Teknova Inc ranked by their cash flow conversion efficiency. Also see Alpha Teknova Inc stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Monash Ivf Group Ltd
AU:MVF
|
0.067x |
|
Somboon Advance Technology Public Company Limited
BK:SAT
|
0.043x |
|
Shining Building Business Co Ltd
TW:5531
|
0.006x |
|
Chung Hwa Food Industrial Co Ltd
TWO:4205
|
0.074x |
|
Nanexa AB
ST:NANEXA
|
-0.073x |
|
Grupo Hotelero Santa Fe SAB
MX:HOTEL
|
0.019x |
|
TBI Motion Technology Co Ltd
TW:4540
|
-0.091x |
|
Atrys Health SL
MC:ATRY
|
-0.032x |
Annual Cash Flow Conversion Efficiency for Alpha Teknova Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Alpha Teknova Inc from 2019 to 2025. Review cash generation quality of Alpha Teknova Inc to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $68.78 Million | $-8.65 Million | -0.126x | +16.41% |
| 2024-12-31 | $82.39 Million | $-12.39 Million | -0.150x | +28.03% |
| 2023-12-31 | $90.04 Million | $-18.81 Million | -0.209x | +23.82% |
| 2022-12-31 | $99.89 Million | $-27.40 Million | -0.274x | -333.15% |
| 2021-12-31 | $143.20 Million | $-9.07 Million | -0.063x | -232.49% |
| 2020-12-31 | $52.41 Million | $2.50 Million | 0.048x | -71.59% |
| 2019-12-31 | $12.91 Million | $2.17 Million | 0.168x | -- |
About Alpha Teknova Inc
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sam… Read more